A lipid-, sugar-, and glycoprotein-rich apical extracellular matrix (aECM) shapes and protects the narrowest tubes in the body. For example, lung surfactant helps narrow airways remain open, and a glycocalyx ("sweet husk") lines capillaries in the vascular system. Damage to the aECM may contribute to diseases of tube integrity such as chronic obstructive pulmonary disease and microvascular disease. Nevertheless, the roles that specific aECM components play in matrix organization and tube protection remain poorly understood. To study aECM in narrow tube maintenance, our lab uses the C. elegans excretory system, a simple conduit composed of three tandem, unicellular tubes. In particular, we have focused on understanding the maintenance of the excretory system's middle tube, the duct cell, as it elongates during embryogenesis. Genetic screening has identified apically secreted proteins that are required to maintain the duct lumen, including LET-653, which contains a Zona Pellucida (ZP) domain. ZP proteins are highly abundant in many aECMs, and ZP protein dysfunction is associated with human diseases, including chronic kidney disease and the microvascular disease hereditary hemorrhagic telangiecstasia (HHT), but how ZP proteins protect tube integrity is still unclear. ZP domains consist of two parts, ZP-N and ZP-C. In vitro studies suggest that ZP-N domains can polymerize to form fibrils, while ZP-C domains regulate ZP-N polymerization and/or bind specific partners to alter signaling. However, we found that the LET-653 ZP-C domain is sufficient to rescue
let-653 mutants and to form a stable (though transient) layer in the aECM; we are now testing if it can polymerize on its own and are seeking to identify its potential partners. We sought to identify LET-653 interactors by screening for suppressors. Surprisingly, we found that loss of SCAV-2, a putative scavenger receptor, bypasses the requirements for LET-653 and several other aECM components. Scavenger receptors can transport lipids and the enzymes that process them; thus, scavenger receptors may regulate the amounts or types of lipids reaching the aECM.
let-653 mutants show increased DiI staining of aECM lipids, suggesting that aberrant lipid accumulation may underlie
let-653 phenotypes. Continuing work will identify the lipid classes that may interact with LET-653 in the aECM, and describe how SCAV-2 may regulate these lipids to alter the aECM.